The Global Association for PKU has been formed to close gaps in care for people who have PKU across the world. This means improving access to screening, treatment and seeking a cure.

PKU is a rare genetic disorder in which the body is unable to correctly metabolise an amino acid in protein, phenylalanine. Phenylalanine is a neurotoxin so left untreated people it builds up in the brain causing serious neurological symptoms including seizures and intellectual impairment.

PKU can be simply and quickly diagnosed via the “heel prick” test and if treatment begins immediately most people with this condition will live healthy lives. Currently 65% of babies born in the world miss out on this opportunity.